Brain manifestation and modulation of pain from myofascial trigger points

Current Pain and Headache Reports

Volumn 13, Issue 5, 2009, Pages 370-375

  Niddam, David M ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANESTHETIC AGENT;

ACETYLCHOLINE RELEASE; BRAIN FUNCTION; BRAIN REGION; CLINICAL FEATURE; ELECTROACUPUNCTURE; ELECTROSTIMULATION; ELECTROSTIMULATION THERAPY; EXERCISE; HUMAN; HYPERALGESIA; INTERMETHOD COMPARISON; MAGNETIC STIMULATION; MASSAGE; MUSCLE CONTRACTURE; MUSCULOSKELETAL PAIN; MYOFASCIAL PAIN; NEUROIMAGING; NEUROMODULATION; NEUROMUSCULAR FUNCTION; NOCICEPTION; PAIN; PAIN THRESHOLD; PATHOGENESIS; REVIEW; STRESS; TRANSCUTANEOUS NERVE STIMULATION; TRIGGER POINT;

BRAIN; HUMANS; MYOFASCIAL PAIN SYNDROMES; NERVE NET; PAIN; PAIN MEASUREMENT; STRESS, PSYCHOLOGICAL;

EID: 70349647913     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0060-7     Document Type: Review

References (54)

1. Mense S: Mechanisms of transition from acute to chronic muscle pain [in German]. Orthopade 2004, 33:525-532.
2. Vlaeyen JW, Linton SJ: Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 2000, 85:317-332.
3. Gameiro GH, da Silva Andrade A, Nouer DF, Ferraz de Arruda Veiga MC: How may stressful experiences contribute to the development of temporomandibular disorders? Clin Oral Investig 2006, 10:261-268.
4. Treaster D, Marras WS, Burr D, et al.: Myofascial trigger point development from visual and postural stressors during computer work. J Electromyogr Kinesiol 2006, 16:115-124.
5. McEwen BS: Physiology and neurobiology of stressCand adaptation: central role of the brain. Physiol Rev 2007, 87:873-904.
6. Niddam DM, Chan RC, Lee SH, et al.: Central modulation of pain evoked from myofascial trigger point. Clin J Pain 2007, 23:440-448.
7. Niddam DM, Chan RC, Lee SH, et al.: Central representation of hyperalgesia from myofascial trigger point. Neuroimage 2008, 39:1299-1306.
8. Kuan TS, Hsieh YL, Chen SM, et al.: The myofascial trigger point region: correlation between the degree of irritability and the prevalence of endplate noise. Am J Phys Med Rehabil 2007, 86:183-189.
9. Gerwin RD, Dommerholt J, Shah JP: An expansion of Simons' integrated hypothesis of trigger point formation. Curr Pain Headache Rep 2004, 8:468-475.
10. Gerwin RD, Shannon S, Hong CZ, et al.: Interrater reliability in myofascial trigger point examination. Pain 1997, 69:65-73.
11. Simons DG, Travell JG, Simons L: Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams & Wilkin; 1999.
12. Shah JP, Gilliams EA: Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther 2008, 12:371-384.
13. Johnson M, Martinson M: Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: A meta-analysis of randomized controlled trials. Pain 2007, 130:157-165.
14. Melzack R, Aall PD: Pain mechanisms: a new theory. Science 1965, 150:971-979.
15. Radhakrishnan R, Sluka KA: Deep tissue afferents, but not cutaneous afferents, mediate transcutaneous electrical nerve stimulation-induced antihyperalgesia. J Pain 2005, 6:673-680.
16. Chu J, Neuhauser DV, Schwartz I, Aye HH: The efficacy of automated/ electrical twitch obtaining intramuscular stimulation (atoims/etoims) for chronic pain control: Evaluation with statistical process control methods. Electromyogr Clin Neurophysiol 2002, 42:393-401.
17. Chu J, Takehara I, Li TC, Schwartz I: Electrical twitch obtaining intramuscular stimulation (ETOIMS) for myofascial pain syndrome in a football player. Br J Sports Med 2004, 38:E25.
18. Chu J, Yuen KF, Wang BH, et al.: Electrical twitch-obtaining intramuscular stimulation in lower back pain: A pilot study. Am J Phys Med Rehabil 2004, 83:104-111.
19. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK: Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005, 9:463-484.
20. Peyron R, Laurent B, Garcia-Larrea L: Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 2000, 30:263-288.
21. Tracey I, Mantyh PW: The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
22. Mountz JM, Bradley LA, Modell JG, et al.: Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995, 38:926-938.
23. Di PieroAV, Jones AK, Iannotti F, et al.: Chronic pain: a PET study of the central effects of percutaneous high cervical cordotomy. Pain 1991, 46:9-12.
24. Hsieh JC, Belfrage M, Stone-Elander S, et al.: Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995, 63:225-236.
25. Iadarola MJ, Max MB, Berman KF, et al.: Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995, 63:55-64.
26. Tu CH, Niddam DM, Chao HT, et al.: Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea. Neuroimage 2009, 47:28-35.
27. Kulkarni B, Bentley DE, Elliott R, et al.: Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum 2007, 56:1345-1354.
28. Kupers RC, Svensson P, Jensen TS: Central representation of muscle pain and mechanical hyperesthesia in the orofacial region: A positron emission tomography study. Pain 2004, 108:284-293.
29. Petrovic P, Ingvar M, Stone-Elander S, et al.: A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy. Pain 1999, 83:459-470.
30. Ploghaus A, Narain C, Beckmann CF, et al.: Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001, 21:9896-9903.
31. Fairhurst M, Wiech K, Dunckley P, Tracey I: Anticipatory brainstem activity predicts neural processing of pain in humans. Pain 2007, 128:101-110.
32. Stoeter P, Bauermann T, Nickel R, et al.: Cerebral activation in patients with somatoform pain disorder exposed to pain and stress: An fMRI study. Neuroimage 2007, 36:418-430.
33. Geuze E, Westenberg HG, Jochims A, et al.: Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry 2007, 64:76-85.
34. Yoshihara T, Shigeta K, Hasegawa H, et al.: Neuroendocrine responses to psychological stress in patients with myofascial pain. J Orofac Pain 2005, 19:202-208.
35. Maekawa K, Clark GT, Kuboki T: Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 2002, 3:251-260.
36. Chen JT, Chen SM, Kuan TS, et al.: Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle. Arch Phys Med Rehabil 1998, 79:790-794.
37. Roberts WJ, Elardo SM: Sympathetic activation of A-delta nociceptors. Somatosens Res 1985, 3:33-44.
38. Feldman S, Conforti N: Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. Neuroendocrinology 1980, 30:52-55.
39. Fendler K, Karmos G, Telegdy G: The effect of hippocampal lesion on pituitary-adrenal function. Acta Physiol Acad Sci Hung 1961, 20:293-297.
40. McKenna JE, Melzack R: Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp Neurol 2001, 172:92-99.
41. Thierry AM, Tassin JP, Blanc G, Glowinski J: Selective activation of mesocortical DA system by stress. Nature 1976, 263:242-244.
42. Floresco SB, Todd CL, Grace AA: Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 2001, 21:4915-4922.
43. Halgren E, Walter RD, Cherlow DG, Crandall PH: Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 1978, 101:83-117.
44. Prado WA, Roberts MH: An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res 1985, 340:219-228.
45. Bodnar RJ, Kelly DD, Brutus M, Glusman M: Stress-induced analgesia: neural and hormonal determinants. Neurosci Biobehav Rev 1980, 4:87-100.
46. Wood PB: Mesolimbic dopaminergic mechanisms and pain control. Pain 2006, 120:230-234.
47. Emad Y, Ragab Y, Zeinhom F, et al.: Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. J Rheumatol 2008, 35:1371-1377.
48. Duric V, McCarson KE: Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain 2006, 7:544-555.
49. Lutz J, Jager L, de Quervain D, et al.: White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion-tensor and volumetric imaging study. Arthritis Rheum 2008, 58:3960-3969.
50. He LF: Involvement of endogenous opioid peptides in acupuncture analgesia. Pain 1987, 31:99-121.
51. Kalra A, Urban MO, Sluka KA: Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther 2001, 298:257-263.
52. Millan MJ: Descending control of pain. Prog Neurobiol 2002, 66:355-474.
53. Zubieta JK, Heitzeg MM, Smith YR, et al.: COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003, 299:1240-1243.
54. Zubieta JK, Bueller JA, Jackson LR, et al.: Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005, 25:7754-7762.